CMS提案大幅削減支出，MiMedx和Organogenesis股價暴跌

英為財情

2025/07/15

Investing.com - 在美國醫療保險和醫療補助服務中心(CMS)提出一項將大幅削減皮膚替代品Medicare支出的規則後，MiMedx Group (NASDAQ:MDXG)股價下跌19%，而Organogenesis Holdings (NASDAQ:ORGO)股價暴跌36%。這項提案是2026財年Medicare醫師費用表的一部分，旨在將皮膚替代品重新分類為"附帶供應品"而非...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2551136981"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551136981\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551136981?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-07-15 04:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551136981","market":"sh","top_or_hot":-1,"title":"CMS提案大幅削減支出，MiMedx和Organogenesis股價暴跌","media":"英為財情","content":"<div>\n<p>Investing.com - 在美國醫療保險和醫療補助服務中心(CMS)提出一項將大幅削減皮膚替代品Medicare支出的規則後，MiMedx Group (NASDAQ:MDXG)股價下跌19%，而Organogenesis Holdings (NASDAQ:ORGO)股價暴跌36%。\n這項提案是2026財年Medicare醫師費用表的一部分，旨在將皮膚替代品重新分類為\"附帶供應品\"而非...</p>\n\n<a href=\"https://cn.investing.com/news/stock-market-news/article-2884944\">網頁鏈接</a>\n\n</div>\n","source":"investing_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CMS提案大幅削減支出，MiMedx和Organogenesis股價暴跌</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCMS提案大幅削減支出，MiMedx和Organogenesis股價暴跌\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">英為財情</strong><span class=\"h-time small\">2025-07-15 04:52</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>Investing.com - 在美國醫療保險和醫療補助服務中心(CMS)提出一項將大幅削減皮膚替代品Medicare支出的規則後，MiMedx Group (NASDAQ:MDXG)股價下跌19%，而Organogenesis Holdings (NASDAQ:ORGO)股價暴跌36%。\n這項提案是2026財年Medicare醫師費用表的一部分，旨在將皮膚替代品重新分類為\"附帶供應品\"而非...</p>\n\n<a href=\"https://cn.investing.com/news/stock-market-news/article-2884944\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://cn.investing.com/news/stock-market-news/article-2884944\">英為財情</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CMS","symbol_name":"CMS能源","start_time":0,"source_url":"https://cn.investing.com/news/stock-market-news/article-2884944","article_id":"2551136981","we_media_id":null,"thumbnails":[],"rights":{"source":"investing_news","url":"https://cn.investing.com/news/stock-market-news/article-2884944","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551136981","pubTimestamp":1752526320,"columns":[],"sourceInfo":{"source_id":"investing_news","name":"英为财情新闻"},"weMediaInfo":null,"summary":"Investing.com - 在美國醫療保險和醫療補助服務中心提出一項將大幅削減皮膚替代品Medicare支出的規則後，MiMedx Group 股價下跌19%，而Organogenesis Holdings 股價暴跌36%。根據CMS的説法，這一變更預計將使這些產品的支出減少近90%。Medicare在皮膚替代品上的支出已從2019年的2.56億美元飆升至2024年的超過100億美元，CMS將此歸因於\"濫用定價行為\"以及使用臨床價值證據有限的產品。這項提議的規則將對MiMedx和Organogenesis等專注於皮膚替代品和傷口護理產品的公司產生重大影響。","collect":0,"end_time":0,"defaultTopTitle":"investing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CMS":"CMS能源","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","BK4208":"复合型公用事业","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU2637428348.USD":"NORDEA 1 GLOBAL SUSTAINABLE LISTED REAL ASSETS \"MP\" (USD) INC","BK4585":"ETF&股票定投概念","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","LU2500361329.USD":"NORDEA 1 GLOBAL SUSTAINABLE LISTED REAL ASSETS \"B\" (USD) ACC","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU2346227817.USD":"BGF SUSTAINABLE GLOBAL INFRASTRUCTURE \"A2\" (USD) ACC","BK4588":"碎股","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC"},"translate_title":"MiMedx, Organogenesis Shares Plunge as CMS Proposes Dramatic Spending Cuts","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CMS":1},"content_text":"Investing.com - 在美國醫療保險和醫療補助服務中心(CMS)提出一項將大幅削減皮膚替代品Medicare支出的規則後，MiMedx Group (NASDAQ:MDXG)股價下跌19%，而Organogenesis Holdings (NASDAQ:ORGO)股價暴跌36%。\n這項提案是2026財年Medicare醫師費用表的一部分，旨在將皮膚替代品重新分類為\"附帶供應品\"而非生物製品，以用於Medicare支付目的。根據CMS的説法，這一變更預計將使這些產品的支出減少近90%。\nMedicare在皮膚替代品上的支出已從2019年的2.56億美元飆升至2024年的超過100億美元，CMS將此歸因於\"濫用定價行為\"以及使用臨床價值證據有限的產品。目前皮膚替代品的支付率可高達每平方英寸2,000美元。\n這項提議的規則將對MiMedx和Organogenesis等專注於皮膚替代品和傷口護理產品的公司產生重大影響。這兩家公司的大部分收入都來自於這些治療方法的Medicare報銷。\nCMS管理員Mehmet Oz博士表示：\"我們正在採取有意義的步驟來現代化Medicare，減少浪費，並改善患者護理。我們正在使老年人更容易獲得預防性服務，激勵醫療保健提供者提供真正的結果，並打擊推高成本的濫用行為。\"\n該提案是更廣泛倡議的一部分，旨在減少不必要的支出，同時提高護理質量。其他要素包括專注於慢性疾病預防的新質量措施，以及針對心力衰竭和下背痛的專科護理新支付模式。\n該提議規則的60天評論期將於2025年9月12日結束，如果最終確定，計劃於2026年實施。\n本文由人工智能協助翻譯。更多信息，請參見我們的使用條款。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}